151 related articles for article (PubMed ID: 15375607)
1. Effect of c-ski overexpression on the development of cachexia in mice bearing the Lewis lung carcinoma.
Carbó N; Costelli P; Busquets S; López-Soriano J; López-Soriano FJ; Baccino FM; Argilés JM
Int J Mol Med; 2004 Oct; 14(4):719-23. PubMed ID: 15375607
[TBL] [Abstract][Full Text] [Related]
2. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
Argilés JM; Figueras M; Ametller E; Fuster G; Olivan M; de Oliveira CC; López-Soriano FJ; Isfort RJ; Busquets S
Muscle Nerve; 2008 Feb; 37(2):190-5. PubMed ID: 17912749
[TBL] [Abstract][Full Text] [Related]
3. The Ski proto-oncogene regulates body composition and suppresses lipogenesis.
Leong GM; Kee AJ; Millard SM; Martel N; Eriksson N; Turner N; Cooney GJ; Hardeman EC; Muscat GE
Int J Obes (Lond); 2010 Mar; 34(3):524-36. PubMed ID: 20029376
[TBL] [Abstract][Full Text] [Related]
4. Role of insulin in development of cancer cachexia in nongrowing sarcoma-bearing mice: special reference to muscle wasting.
Svaninger G; Drott C; Lundholm K
J Natl Cancer Inst; 1987 May; 78(5):943-50. PubMed ID: 3553691
[TBL] [Abstract][Full Text] [Related]
5. Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia.
Chai J; Wu Y; Sheng ZZ
Crit Care Med; 2003 Jun; 31(6):1802-7. PubMed ID: 12794423
[TBL] [Abstract][Full Text] [Related]
6. Effects of the PPARgamma agonist GW1929 on muscle wasting in tumour-bearing mice.
Moore-Carrasco R; Figueras M; Ametller E; López-Soriano FJ; Argilés JM; Busquets S
Oncol Rep; 2008 Jan; 19(1):253-6. PubMed ID: 18097603
[TBL] [Abstract][Full Text] [Related]
7. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
[TBL] [Abstract][Full Text] [Related]
8. Multiple organ failure of tumor-bearing rabbits in cancer cachexia is caused by apoptosis of normal organ cells.
Fukuda T; Sumi T; Nobeyama H; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Oncol; 2009 Jan; 34(1):61-7. PubMed ID: 19082478
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice.
Peters SJ; van Helvoort A; Kegler D; Argilès JM; Luiking YC; Laviano A; van Bergenhenegouwen J; Deutz NE; Haagsman HP; Gorselink M; van Norren K
Oncol Rep; 2011 Jul; 26(1):247-54. PubMed ID: 21503587
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
[TBL] [Abstract][Full Text] [Related]
11. Branched-chain amino acids: a role in skeletal muscle proteolysis in catabolic states?
Busquets S; Alvarez B; López-Soriano FJ; Argilés JM
J Cell Physiol; 2002 Jun; 191(3):283-9. PubMed ID: 12012323
[TBL] [Abstract][Full Text] [Related]
12. Effect of iguratimod and other anti-rheumatic drugs on adenocarcinoma colon 26-induced cachexia in mice.
Tanaka K; Urata N; Mikami M; Ogasawara M; Matsunaga T; Terashima N; Suzuki H
Inflamm Res; 2007 Jan; 56(1):17-23. PubMed ID: 17334666
[TBL] [Abstract][Full Text] [Related]
13. The 'cancer cachectic factor'.
Tisdale MJ
Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
[TBL] [Abstract][Full Text] [Related]
14. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals.
Tessitore L; Costelli P; Bonetti G; Baccino FM
Arch Biochem Biophys; 1993 Oct; 306(1):52-8. PubMed ID: 8215420
[TBL] [Abstract][Full Text] [Related]
15. Weight loss in tumour-bearing mice is not associated with changes in resistin gene expression in white adipose tissue.
Gómez-Ambrosi J; Zabalegui N; Bing C; Tisdale MJ; Trayhurn P; Williams G
Horm Metab Res; 2002; 34(11-12):674-7. PubMed ID: 12660881
[TBL] [Abstract][Full Text] [Related]
16. Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing mice.
Nicholson JR; Kohler G; Schaerer F; Senn C; Weyermann P; Hofbauer KG
J Pharmacol Exp Ther; 2006 May; 317(2):771-7. PubMed ID: 16436498
[TBL] [Abstract][Full Text] [Related]
17. DNA fragmentation occurs in skeletal muscle during tumor growth: A link with cancer cachexia?
van Royen M; Carbó N; Busquets S; Alvarez B; Quinn LS; López-Soriano FJ; Argilés JM
Biochem Biophys Res Commun; 2000 Apr; 270(2):533-7. PubMed ID: 10753659
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
Smith HJ; Mukerji P; Tisdale MJ
Cancer Res; 2005 Jan; 65(1):277-83. PubMed ID: 15665304
[TBL] [Abstract][Full Text] [Related]
19. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats.
Temparis S; Asensi M; Taillandier D; Aurousseau E; Larbaud D; Obled A; Béchet D; Ferrara M; Estrela JM; Attaix D
Cancer Res; 1994 Nov; 54(21):5568-73. PubMed ID: 7923198
[TBL] [Abstract][Full Text] [Related]
20. Waste management - cytokines, growth factors and cachexia.
Saini A; Al-Shanti N; Stewart CE
Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]